SolyPlus Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

SolyPlus General Information

Description

Developer of hyaluronic acid and biopolymer products intended to serve medical, pharmaceutical and cosmetic markets. The company's products utilize specialized biopolymer formulations, chemical cross-linking and biocompatibility processing to provide modified hyaluronic acid, active biomaterial bases and custom synthesis, enabling healthcare and cosmetics manufacturers to develop advanced biomaterial applications through specialized manufacturing capabilities.

Contact Information

Formerly Known As
SolyPlus Berlin
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hauptstraße 8
  • 25855 Haselund
  • Germany
+49 04843
Primary Industry
Specialty Chemicals
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • Hauptstraße 8
  • 25855 Haselund
  • Germany
+49 04843

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SolyPlus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 26-Apr-2021 Completed Generating Revenue
2. Equity Crowdfunding 17-Nov-2020 Completed Generating Revenue
1. Early Stage VC 01-Jan-2020 Completed Generating Revenue
To view SolyPlus’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SolyPlus Patents

SolyPlus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3202259-A1 Means and methods of preventing, treating and detecting infections Pending 22-Dec-2020
EP-4267148-A1 Means and methods of preventing, treating and detecting infections Pending 22-Dec-2020
US-20240050366-A1 Means and methods of preventing, treating and detecting infections Pending 22-Dec-2020
WO-2022135767-A1 Means and methods of preventing, treating and detecting infections Inactive 22-Dec-2020
CA-3171226-A1 Means and methods of preventing and treating infections Pending 15-Apr-2020 A61K31/722
To view SolyPlus’s complete patent history, request access »

SolyPlus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SolyPlus Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Förde Ventures Venture Capital Minority
MBG Schleswig-Holstein PE/Buyout Minority
Seed and Startup Fund Schleswig-Holstein Venture Capital Minority
To view SolyPlus’s complete investors history, request access »

SolyPlus FAQs

  • When was SolyPlus founded?

    SolyPlus was founded in 2016.

  • Where is SolyPlus headquartered?

    SolyPlus is headquartered in Haselund, Germany.

  • What is the size of SolyPlus?

    SolyPlus has 5 total employees.

  • What industry is SolyPlus in?

    SolyPlus’s primary industry is Specialty Chemicals.

  • Is SolyPlus a private or public company?

    SolyPlus is a Private company.

  • What is SolyPlus’s current revenue?

    The current revenue for SolyPlus is .

  • How much funding has SolyPlus raised over time?

    SolyPlus has raised $599K.

  • Who are SolyPlus’s investors?

    Förde Ventures, MBG Schleswig-Holstein, and Seed and Startup Fund Schleswig-Holstein have invested in SolyPlus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process